1637 cation, 10 particularly in acute promyelocytic leukemia (APL), we searched for genomic similarities. The few specific studies in existence on sequence analysis of the PML-RAR␣ gene show that the breakpoint within the involved gene (usually the PML locus) is variably situated, and that the corresponding fusion transcript should be aberrant. The resulting PML-RAR␣ proteins contained residues not homologous with either PML or RAR␣. These reported atypical breaks were very similar to the one recorded in our case. A second original characteristic of the BCR break reported by us is that an intronic sequence derived from abl intron Ib was juxtaposed to bcr exon. This is another unprecedented feature for a CML patient, although on rare occasions it has been reported in AML patients. 10 So, it may be speculated that in a small proportion of the DNA breaks that occurs in leukemia, a currently unknown molecular mechanism could break the coding DNA. The resulting RNA remains in-frame coding an aberrant or, as in our case, variant oncogenic protein. The involvement of the Translin protein or Translin related protein (TRAX) 8 in the generation of our cases is strongly supported by the fact that homology sequences were present on both sides of the genes involved in the rearrangement. These observations support the hypothesis that the role of Translin could be more important in CML patients translocation than in other non-lymphoid leukemia-associated rearrangements. It is now well demonstrated that different types of small B cell lymphomas may comprise a lympho-plasmacytoid/lymphoplasmacytic component. Immunohistochemistry demonstrates the presence of monotypic immunoglobulin in the cytoplasm, in the perinuclear cisternae and sometimes in expansion of this cisternae realizing intranuclear vacuoles 3 described by Dutcher and Fahey. 4 These vacuoles can also be disclosed by PAS staining, when the heavy chain is of the mu type.
At least three different types of small B cell lymphomas other than lymphoplasmacytic lymphoma can be associated with a WM presentation. This variant of B-CLL accepted in the new WHO classification which is in progress, 5 corresponds to the lympho-plasmacytoid type of immunocytoma described in the up-dated Kiel classification 6 based on the proposals of K Lennert distinguishing two subtypes of immunocytomas, the lymphoplasmacytoid and the lymphoplasmacytic. One of us (JD) reported many years ago such a case, which transformed 5 years after publication into a typical WM. 7 (3) primary splenic marginal zone lymphoma represents another example of such an association. We are now reporting a series of 31 cases of this type of lymphoma. 8 A lymphoplasmacytic component secreting intra-cytoplasmic monotypic immunoglobulins has been demonstrated by immunohistochemistry on frozen and/or paraffin embedded tissue in 23 cases. In all cases which had an iliac crest trephine biopsy, the bone marrow was involved by the same immunoglobulin secreting lymphoplasmacytic component. For eight cases, out of these 23, we had no information about the presence or absence of seric monoclonal component. Four cases had no seric spike. In four patients, a minimal seric monoclonal component was present, less than 5 g/l. But in seven cases with a seric monoclonal component higher than 5 g/l, the diagnosis of MW has been proposed. Eleven patients of this group also had auto-immune disorders, particularly auto-immune hemolytic anaemia.
The eight patients without such a lymphoplasmacytic cell component in the spleen had no seric monoclonal immunoglobulin, and no auto-immune disorders.
In addition, we have disclosed a lymphoplasmacytic cell component producing a monotypic immunoglobulin in nodal monocytoid B cell lymphoma and even in one case of follicular B cell ML with marginal zone differentiation. These lymphomas may also perhaps be responsible in a few number of patients for such a WM.
Finally, at the present time, the lymphoplasmacytoid/lymphoplasmacytic cell population infiltrating the bone marrow and responsible for the seric monoclonal component in MW can represent one part of the lymphomatous proliferation of at least four different disseminated lymphomas constituted by small B cells: MALT lymphoma, splenic marginal zone lymphoma and nodal monocytoid B cell lymphoma on the one hand, and B-CLL with a lymphoplasmacytoid differentiation on the other hand.
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